Camillo Porta
Brigham and Women's Hospital
2 papers in the Anchorcite directory, published between 2008 and 2018, cited 18,007 times in total.
ORCID profileResearch topics
- Renal cell carcinoma treatment · 2 papers
- Colorectal Cancer Treatments and Studies · 1 paper
- Hepatocellular Carcinoma Treatment and Prognosis · 1 paper
- Cancer Immunotherapy and Biomarkers · 1 paper
- Ferroptosis and cancer prognosis · 1 paper
Frequent co-authors
- Josep Maria Llovet · 1 paper
- Sergio Ricci · 1 paper
- Vincenzo Mazzaferro · 1 paper
- Philip a. Hilgard · 1 paper
- Edward John Gane · 1 paper
- Jean Frédéric Blanc · 1 paper
- André Cosme de Oliveira · 1 paper
- Armando Santoro · 1 paper
Papers
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine · 2008 · 13,250 citations
BACKGROUND: No effective systemic therapy exists for patients with advanced hepatocellular carcinoma. A preliminary study suggested that sorafenib, an oral multikinase inhibitor of the vascular endothelial growth factor receptor, the platelet-derived growth factor receptor, and Raf may be effective in…
- Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell CarcinomaNew England Journal of Medicine · 2018 · 4,757 citations
BACKGROUND: Nivolumab plus ipilimumab produced objective responses in patients with advanced renal-cell carcinoma in a pilot study. This phase 3 trial compared nivolumab plus ipilimumab with sunitinib for previously untreated clear-cell advanced renal-cell carcinoma. METHODS: We randomly assigned adults in…
Metadata from OpenAlex (CC0).